As previously shown for NKG2D [28], these results suggest that the expression of SLAMF7, NKG2D, and GITR may be downregulated when they encounter high levels of their ligands on myeloma cells or perhaps soluble ligands shed from tumors (not measured in this study). The gene discussed is KLRK1; the disease is plasma cell myeloma.